查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494772

到 2030 年骨生长刺激器市场预测：按产品类型、分销管道、应用、最终用户和地区进行的全球分析

Bone Growth Stimulators Market Forecasts to 2030 - Global Analysis By Product Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球骨生长刺激剂市场规模为 23 亿美元，预计在预测期内将以 12.1% 的复合年增长率增长，到 2030 年达到 46 亿美元。

骨骼生长刺激器是医疗设备。对骨折或骨癒合部位施加电或超音波刺激，以促进新骨组织的形成。当骨骼癒合缓慢或有阻止正常骨骼生长的疾病时，该技术特别有用。透过加速癒合过程，骨骼生长刺激器可以缩短恢復时间，最大限度地减少併发症，并改善骨折、骨不连和其他骨骼相关损伤和病症患者的整体预后。

根据《世界人口展望》2019 年修订数据，2019 年，每 11 人中就有 1 人年龄在 65 岁或以上。到 2050 年，这一数字预计将上升至六分之一。

骨折和骨质疏鬆症增加

由于担心骨折和骨质疏鬆症患者数量不断增加，市场需求激增。这种趋势在人口老化中尤其明显，凸显了对有效治疗方案的需求。随着老龄化，骨骼密度下降，使我们更容易发生骨折和骨质疏鬆症相关併发症。因此，人们对促进骨癒合和再生的骨生长刺激剂的信心不断增强，从而推动了市场的成长。

潜在的副作用

该市场的突出特点是潜在副作用方面的挑战。确保安全性和有效性，同时最大限度地减少副作用仍然是一个关键问题。常见的副作用包括刺激部位的皮肤刺激、不适和罕见的过敏反应。此外，需要彻底的监测和监管，以解决组织损伤和骨不连等长期影响。平衡创新和安全措施对于该行业的信心和市场生存至关重要。

脊椎融合手术增加

市场需求激增，特别是由于脊椎融合手术的普及普及。这一趋势是由多种因素推动的，包括人口老化、脊椎疾病的增加以及医疗技术的进步。因此，骨骼生长刺激器的采用显着增加，特别是在脊椎融合手术中。这是因为医疗保健专业人员正在寻找有效的方法来提高骨癒合和固定率，最终改善患者的治疗效果。

设备高成本

该市场的特点是设备成本高，这是许多患者进入该市场的主要障碍。这些旨在帮助骨癒合和再生的设备通常价格昂贵，限制了可用性和负担能力。儘管它们在加速康復和改善骨折和整形外科疾病的预后方面具有潜在的好处，但与这些刺激器相关的高成本阻碍了公平地获得这一重要的医疗技术，这是这样做的一个挑战。

COVID-19 的影响：

COVID-19 的爆发对骨生长刺激剂市场产生了重大影响。由于这些医疗资源被用于危机管理，包括整形外科手术在内的选择性手术面临延误，影响了对骨生长刺激剂的需求。此外，供应链中断和经济不确定性阻碍了市场成长。然而，随着医疗保健系统的稳定和手术的恢復，由于整形外科疾病盛行率的上升和骨刺激技术的进步，市场预计将逐渐復苏。

脊椎融合手术部分预计将成为预测期内最大的部分

脊椎融合手术预计将成为预测期内最大的部分。随着脊椎融合手术领域的增加，对这些刺激器的需求也增加。技术进步、老年人口增加和脊椎疾病流行等因素正在推动市场扩张。此外，有利的报销政策和不断提高的患者意识进一步促进了市场成长，使其成为医疗设备业内一个充满希望的领域。

医院和诊所领域预计在预测期内复合年增长率最高

医院和诊所产业预计在预测期内复合年增长率最高。这些设施利用最尖端科技，包括电磁和超音波骨骼生长刺激器，提供从诊断到治疗的全面护理。透过专注于以患者为中心的护理，医院和诊所正在确保有效的康復和康復，推动骨生长刺激剂市场的成长，并改善患有骨相关疾病的患者的治疗结果。

比最大的地区

由于整形外科疾病数量不断增加和人口老化，预计北美在预测期内将占据最大的市场占有率。医疗设备的技术进步，加上患者和医疗保健专业人员对骨生长刺激剂益处的认识不断提高，进一步推动了市场扩张。此外，有利的报销政策和医疗基础设施投资也有助于市场扩张。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。骨骼生长刺激技术的不断进步正在导致更有效和高效的设备的开发。世界各国政府正在采取倡议改善医疗基础设施并加速先进医疗技术的采用。这包括努力减轻肌肉骨骼疾病的负担和改善患者的治疗结果。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球骨生长刺激器市场：依产品类型

  • 骨骼生长刺激剂
    • 电容耦合装置
    • 组合磁场装置
    • 植入式骨生长刺激器
    • 超音波骨刺激器
  • 骨形成蛋白（BMP）
  • 血小板衍生生长因子 (PDGF)
  • 其他产品类型

第六章全球骨生长刺激器市场：按分销管道

  • 直销
  • 代理销售
  • 网路零售商
  • 药局/专卖店

第七章全球骨生长刺激器市场：按应用

  • 断裂
  • 脊椎融合手术
  • 牙科和颚颜面
  • 骨关节炎和骨质疏鬆症
  • 软组织修復
  • 其他用途

第八章全球骨生长刺激器市场：依最终用户分类

  • 医院和诊所
  • 日间手术中心 (ASC)
  • 居家照护环境
  • 其他最终用户

第九章全球骨生长刺激器市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Orthologic Corp.
  • Medtronic plc
  • Harvest Technologies Corp.
  • Amedica Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Orthofix Medical Inc.
  • Bone Solutions Inc.
  • Bioventus LLC
  • Arthrex, Inc.
  • Isto Technologies, Inc.
  • Stryker Corporation
Product Code: SMRC26287

According to Stratistics MRC, the Global Bone Growth Stimulators Market is accounted for $2.3 billion in 2024 and is expected to reach $4.6 billion by 2030 growing at a CAGR of 12.1% during the forecast period. Bone growth stimulators are medical devices designed to enhance the natural healing process of bones. They work by applying electrical or ultrasound stimulation to the site of a fracture or a bone fusion, promoting the formation of new bone tissue. This technology is particularly useful in cases where bones are slow to heal or when there are conditions that hinder normal bone growth. By accelerating the healing process, bone growth stimulators can reduce recovery time, minimize complications, and improve overall outcomes for patients with fractures, non-unions, or other bone-related injuries or conditions.

According to the World Population Prospects, 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

Market Dynamics:

Driver:

Rising incidence of bone fractures and osteoporosis

The market has witnessed a surge in demand owing to a concerning rise in bone fractures and osteoporosis cases. This trend, particularly prevalent in aging populations, underscores the need for effective treatment options. As individuals age, bone density decreases, increasing susceptibility to fractures and osteoporosis-related complications. Consequently, there's a growing reliance on bone growth stimulators to facilitate bone healing and regeneration, driving market growth.

Restraint:

Potential side effects

In the market, challenges related to potential side effects loom prominently. Ensuring safety and efficacy while minimizing adverse reactions remains a critical concern. Common side effects include skin irritation at the stimulation site, discomfort, and rare cases of allergic reactions. Moreover, there's a need for thorough monitoring and regulatory oversight to address long-term impacts, such as tissue damage or bone nonunion. Balancing innovation with safety measures is paramount for sustaining trust and market viability in this field.

Opportunity:

Increasing number of spinal fusion surgeries

The market has witnessed a surge in demand, notably attributed to the increasing prevalence of spinal fusion surgeries. This trend is fueled by various factors such as aging populations, rising incidences of spinal disorders, and advancements in medical technology. Consequently, there has been a notable uptick in the adoption of bone growth stimulators, particularly in spinal fusion procedures, as healthcare professionals seek effective methods to enhance bone healing and fusion rates, ultimately improving patient outcomes.

Threat:

High cost of devices

The market is marked by the high cost of devices, posing a significant barrier to access for many patients. These devices, designed to aid in bone healing and regeneration, often come with substantial price tags, limiting their availability and affordability. Despite their potential benefits in accelerating recovery and improving outcomes for fractures and orthopedic conditions, the steep costs associated with these stimulators present challenges in ensuring equitable access to this crucial medical technology.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the Bone Growth Stimulators market. With these healthcare resources redirect towards managing the crisis, elective procedures, including orthopedic surgeries, faced delays, affecting the demand for bone growth stimulators. Additionally, supply chain disruptions and economic uncertainties hindered market growth. However, as healthcare systems stabilize and surgeries resume, the market is expected to recover gradually, driven by the rising prevalence of orthopedic conditions and advancements in bone stimulation technology.

The spinal fusion segment is expected to be the largest during the forecast period

The spinal fusion is expected to be the largest during the forecast period. With an increasing number of spinal fusion procedures globally, the demand for these stimulators is escalating. Factors such as technological advancements, rising geriatric population, and the prevalence of spinal disorders are driving market expansion. Additionally, favorable reimbursement policies and growing awareness among patients are further contributing to market growth, making it a promising sector within the medical devices industry.

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period

The hospitals and clinics segment is expected to have the highest CAGR during the forecast period. These facilities provide comprehensive care, from diagnosis to therapy, leveraging cutting-edge technologies such as electromagnetic and ultrasound bone growth stimulators. With a focus on patient-centered care, hospitals and clinics ensure effective rehabilitation and recovery, driving the growth of the bone growth stimulators market and improving outcomes for individuals with bone-related ailments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period driven by increasing incidences of orthopedic conditions and a rising aging population. Technological advancements in medical devices, coupled with growing awareness among patients and healthcare professionals regarding the benefits of bone growth stimulators, are further fueling market expansion. Additionally, favorable reimbursement policies and investments in healthcare infrastructure contribute to market growth.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Continuous advancements in bone growth stimulation technology have led to the development of more effective and efficient devices. Governments in various countries are taking initiatives to improve healthcare infrastructure and promote the adoption of advanced medical technologies. This includes initiatives to reduce the burden of musculoskeletal disorders and improve patient outcomes.

Key players in the market

Some of the key players in Bone Growth Stimulators market include Orthologic Corp., Medtronic plc, Harvest Technologies Corp., Amedica Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Orthofix Medical Inc., Bone Solutions Inc., Bioventus LLC, Arthrex, Inc., Isto Technologies, Inc., Stryker Corporation.

Key Developments:

In December 2023, Orthofix Medical Inc. announced the new data that supported the safety and efficacy of PEMF Stimulation in Lumbar Spine Fusion Procedures indicated for patients with the risk of pseudarthrosis.

In February 2022, Orthofix Medical Inc. introduced a new synthetic bioactive bone graft solution called Opus B.A., which is used for cervical and lumbar spine fusion procedures.

Product Types Covered:

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins (BMPs)
  • Platelet-Derived Growth Factor (PDGF)
  • Other product Types

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Retailers
  • Pharmacies and Specialty Stores

Applications Covered:

  • Fractures
  • Spinal Fusion
  • Dental and Maxillofacial
  • Osteoarthritis and Osteoporosis
  • Soft Tissue Repair
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bone Growth Stimulators Market, By Product Type

  • 5.1 Introduction
  • 5.2 Bone Growth Stimulation Devices
    • 5.2.1 Capacitive Coupling Devices
    • 5.2.2 Combined Magnetic Field Devices
    • 5.2.3 Implantable Bone Growth Stimulators
    • 5.2.4 Ultrasonic Bone Stimulators
  • 5.3 Bone Morphogenetic Proteins (BMPs)
  • 5.4 Platelet-Derived Growth Factor (PDGF)
  • 5.5 Other product Types

6 Global Bone Growth Stimulators Market, By Distribution Channel

  • 6.1 Introduction
  • 6.2 Direct Sales
  • 6.3 Distributors
  • 6.4 Online Retailers
  • 6.5 Pharmacies and Specialty Stores

7 Global Bone Growth Stimulators Market, By Application

  • 7.1 Introduction
  • 7.2 Fractures
  • 7.3 Spinal Fusion
  • 7.4 Dental and Maxillofacial
  • 7.5 Osteoarthritis and Osteoporosis
  • 7.6 Soft Tissue Repair
  • 7.7 Other Applications

8 Global Bone Growth Stimulators Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Ambulatory Surgical Centers (ASCs)
  • 8.4 Home Care Settings
  • 8.5 Other End Users

9 Global Bone Growth Stimulators Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Orthologic Corp.
  • 11.2 Medtronic plc
  • 11.3 Harvest Technologies Corp.
  • 11.4 Amedica Corporation
  • 11.5 Zimmer Biomet Holdings, Inc.
  • 11.6 Smith & Nephew plc
  • 11.7 Orthofix Medical Inc.
  • 11.8 Bone Solutions Inc.
  • 11.9 Bioventus LLC
  • 11.10 Arthrex, Inc.
  • 11.11 Isto Technologies, Inc.
  • 11.12 Stryker Corporation

List of Tables

  • Table 1 Global Bone Growth Stimulators Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Bone Growth Stimulators Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Bone Growth Stimulators Market Outlook, By Bone Growth Stimulation Devices (2022-2030) ($MN)
  • Table 4 Global Bone Growth Stimulators Market Outlook, By Capacitive Coupling Devices (2022-2030) ($MN)
  • Table 5 Global Bone Growth Stimulators Market Outlook, By Combined Magnetic Field Devices (2022-2030) ($MN)
  • Table 6 Global Bone Growth Stimulators Market Outlook, By Implantable Bone Growth Stimulators (2022-2030) ($MN)
  • Table 7 Global Bone Growth Stimulators Market Outlook, By Ultrasonic Bone Stimulators (2022-2030) ($MN)
  • Table 8 Global Bone Growth Stimulators Market Outlook, By Bone Morphogenetic Proteins (BMPs) (2022-2030) ($MN)
  • Table 9 Global Bone Growth Stimulators Market Outlook, By Platelet-Derived Growth Factor (PDGF) (2022-2030) ($MN)
  • Table 10 Global Bone Growth Stimulators Market Outlook, By Other product Types (2022-2030) ($MN)
  • Table 11 Global Bone Growth Stimulators Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 12 Global Bone Growth Stimulators Market Outlook, By Direct Sales (2022-2030) ($MN)
  • Table 13 Global Bone Growth Stimulators Market Outlook, By Distributors (2022-2030) ($MN)
  • Table 14 Global Bone Growth Stimulators Market Outlook, By Online Retailers (2022-2030) ($MN)
  • Table 15 Global Bone Growth Stimulators Market Outlook, By Pharmacies and Specialty Stores (2022-2030) ($MN)
  • Table 16 Global Bone Growth Stimulators Market Outlook, By Application (2022-2030) ($MN)
  • Table 17 Global Bone Growth Stimulators Market Outlook, By Fractures (2022-2030) ($MN)
  • Table 18 Global Bone Growth Stimulators Market Outlook, By Spinal Fusion (2022-2030) ($MN)
  • Table 19 Global Bone Growth Stimulators Market Outlook, By Dental and Maxillofacial (2022-2030) ($MN)
  • Table 20 Global Bone Growth Stimulators Market Outlook, By Osteoarthritis and Osteoporosis (2022-2030) ($MN)
  • Table 21 Global Bone Growth Stimulators Market Outlook, By Soft Tissue Repair (2022-2030) ($MN)
  • Table 22 Global Bone Growth Stimulators Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 23 Global Bone Growth Stimulators Market Outlook, By End User (2022-2030) ($MN)
  • Table 24 Global Bone Growth Stimulators Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 25 Global Bone Growth Stimulators Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 26 Global Bone Growth Stimulators Market Outlook, By Home Care Settings (2022-2030) ($MN)
  • Table 27 Global Bone Growth Stimulators Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.